scholarly journals Supplementation with omega fatty acids increases the mRNA expression level of PLA2G4A in patients with gastric cancer

2018 ◽  
Vol 9 (6) ◽  
pp. 1176-1183 ◽  
Author(s):  
Donya Bazhan ◽  
Mahmoud Shekari Khaniani
2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Kim Hyemi ◽  
Wen Yanran ◽  
Wang Shuang ◽  
Ko Kwangsuk

Abstract Objectives Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of lipid in hepatocytes. In spite of the growing number of NAFLD patients with the increased prevalence of obesity, the pathogenesis of NAFLD remains to be fully elucidated. Prohibitin1 (Phb1) is an evolutionarily conserved protein, which is expressed predominantly on the inner mitochondrial membrane. Several studies have provided evidences that the Phb1 plays a crucial role not only in proliferation of hepatocytes, but also in lipid metabolism in adipocytes. Since the liver is the major site for lipid metabolism, this study was aimed to understand the lipid metabolism regulated by Phb1 in hepatocytes. Methods Normal murine hepatocyte cell line, AML12 was used in this study and Phb1 was disrupted by small interfering RNA (siRNA). These siRNA transfected cells were further treated with saturated fatty acids (SFAs), palmitic acid (PA) for 24 hours. Then the cell viability and the mRNA expression level of key enzymes involved in lipid metabolism were determined. Results Approximately 20% cell viability decreased when Phb1 was silenced and the cell viability diminished dramatically after PA treatment in both control and Phb1 deficiency groups. Without excessive fatty acids (FAs) inside the cells, Phb1 deficiency led to significant mRNA expression of stearoyl-CoA desaturase-1 (Scd1) to generate triglycerides (TG) and activated the endoplasmic reticulum (ER) stress response by upregulating the mRNA expression level of C/EBP homologous protein (Chop). The elevated expression of peroxisome proliferator activated receptor gamma (PPARγ), which was reported to be upregulated in the livers of NAFLD patients, was also found in this study. When intracellular FAs were surplus, the catabolism of FAs was inhibited by downregulation of carnitine palmitoyltransferase 1a (Ctp1a), while the synthesis of TG was further promoted by significantly increased mRNA expression level of Scd1. The elevated mRNA expression level of Chop and Pparγ induced by Phb1 disruption were further elevated. Conclusions This study, Phb1 deficiency led to altered lipid metabolism, resulting in the of lipid accumulation inside the cells and ER stress, and these cytotoxic effects were further deteriorated upon the excessive PA treatment. Funding Sources National Research Foundation of Korea, 2-1604-001.


Diagnostics ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. 595
Author(s):  
Ji Young Park ◽  
Sung-Bae Park ◽  
Heechul Park ◽  
Jungho Kim ◽  
Ye Na Kim ◽  
...  

There have been few reports on the kinetics of hemodialyzed (HD) patients’ immune responses in latent tuberculosis infection (LTBI). Therefore, in the present study, messenger ribonucleic acid (mRNA) expression levels of nine immune markers were analyzed to discriminate between HD patients with LTBI and healthy individuals. Nine cytokines and chemokines were screened through relative mRNA expression levels in whole blood samples after stimulation with Mycobacterium tuberculosis (MTB)-specific antigens from HD patients with LTBI (HD/LTBI), HD patients without LTBI, and healthy individuals, and results were compared with the QuantiFERON-TB Gold In-Tube (QFT-GIT) test. We confirmed that the C-C motif chemokine 11 (CCL11) mRNA expression level of the HD/LTBI group was significantly higher than the other two groups. Especially, the CCL11 mRNA expression level of the >0.7 IU/mL group in the QFT-GIT test was significantly higher than the <0.2 IU/mL group in the QFT-GIT test and the 0.2–0.7 IU/mL group in the QFT-GIT test (p = 0.0043). The present study reveals that the relative mRNA expression of CCL11 was statistically different in LTBI based on the current cut-off value (i.e., ≥0.35 IU/mL) and in the >0.7 IU/mL group. These results suggest that CCL11 mRNA expression might be an alternative biomarker for LTBI diagnosis in HD patients.


2010 ◽  
Vol 9 (11) ◽  
pp. 1659-1666 ◽  
Author(s):  
Er-lin LI ◽  
Xin-hua XIE ◽  
Ye-fen XU ◽  
Zhuang XIE ◽  
Ling CHEN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document